Skip to main content
Skip to content
Case File
efta-efta01179040DOJ Data Set 9Other

UPCOMING

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01179040
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
UPCOMING EVENTS WIS, Well-Being in the Information Society, 2012 August 22,24, Turku, Finland Swedish-American Life Science Summit 2012 August 22-24. Stockholm, Sweden www_salss.ccnn RioPartnering Latin America September 11.13. Rio de Janein, Brazil www.techvision.com/bpl Medtecb Investment Day Nordic September 13, Stockholm, Sweden www.medwchinvestmentday.com BioPharm America 2012 September 19.21, Boston, MA, USA wrovebdgroup,sem/bpa BiePartnering Europe October 7-9, Brussels, Belgium wwwtechvision.com/bpfe CPU Worldwide 2012 October 9.11, Madrid, Spain www.cphi,com European NledTech Thrum October 10-12, Brussels. Belgium www.medtechfor MOM BIG-Europe 2012 November 12-14, Hamburg, Germany wwwebdgroup.com/bioeurope UPCOMING EVENTS What will the theme be for this year's conference? "The 2012 Summit will focus on the globalization of the healthcare market, with an emphasis on Asia, diabetes and digital health. Our original mis- sion was to help enable transactions between America, the largest market in the world, and Sweden, one of the most innovative life science countries. However, over the last few years the sum- mit has seen an increased participation from many other countries including China, Japan, India, Singapore, Korea, Brazil and Israel. China is arguably the most attractive emerging pharmaceuti- cal market, growing by more than 20 percent a year. But we need to under- stand the market better to fully capture its potential. Diabetes is a global public health crisis. One in ten adults will have diabetes by 2030, posing a huge chal- lenge to healthcare systems worldwide. So this is a public health crisis that we need to shed more light on," Sana Alaj- movic explains. Sana Alajmovic goes on to say, "When thinking about globalization of health- care, it is only fitting to consider how wireless technologies are being utilized in different parts of the world as well as how these products may improve health worldwide. The u.s. is ahead of Sweden at incorporating technology to provide and facilitate healthcare, but it's just a matter of time before we will be seeing more of this in Sweden. Mobile appli- cations in particular are a fast growing trend in the u.s." This is the eighth time that the summit has been arranged. What impact do you think that SALSS has on the life science industry? "The Swedish life science industry is currently undergoing a structural transformation with big pharma out- sourcing R&D to smaller research com- panies, institutions and universities. The shutting down of the AstraZeneca R&D site in Sodertalje is an example of that. By creating this global platform we hope to highlight the latest trends within business, build a forum for debate and establish new contacts and new business opportunities. By introducing u.s. investors, and at the same time promoting Swedish life science, we hope to create investment possibilities. Hopefully, we can also contribute to col- laborations being initiated and provide some inspiration," states Sana Alajmovic. What is the view on Sweden as a life science nation in the US? "Very positive. In the u.s, both Sweden as a country and the Swedish life science- industry have excellent reputations. Swedes are known to be easy to work with, innovative, flexible and skilled workers. In relation to its Doe, Sweden is one of the world's largest spenders on R&D. Historically the country has had a strong position and we see not only u.s. investors but also investors from Asia be- coming interested in Sweden. However, there is room for improvement when it comes to commercializing our research, compared to the u.s," Sana Alajmovic concludes. ■ What is the difference between you and your competitor? We help you secure your advantage. Contact us on +46 8 5988 7200 or read more on www.albihnszacco.se aLBIHNs.zacco 58 NORDIC LIFE SCIENCE REVIEW EFTA01179040

Technical Artifacts (5)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainwww.medwchinvestmentday.com
Domainwww.techvision.com
Domainwwwebdgroup.com
Domainwwwtechvision.com
Phone+46 8 5988 7200

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.